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INTRODUCTION:  Primary  Pulmonary  Mucinous  Cystadenocarcinoma  PPMC  is  an extremely  rare  subtype
of  pulmonary  adenocarcinoma,  with  only  a few  dozen  cases  reported  in  the  literature  to date.
PRESENTATION OF  CASE:  We  report  a extremely  rare  case  of  pulmonary  mucinous  cystadenocarcinoma
presenting  as a  pleural  mesothelioma.  53-year-old  man  exposed  to  asbestos,  he is  admitted  in  hospital
with  a 5  cm mass  in  right  pleura.  He  was  treated  by  wedge  resection.  Sparse  groups  of  malignant  cells were
microscopically  observed  in  pools  of  mucin.  The  postoperative  histopathological  ﬁndings  were  in  accor-
dance  with  the  diagnosis  of pulmonary  mucinous  cystadenocarcinoma  on  cystic  adenoid  malformation
of  lung.  5 years  later,  the  patient  has  no  recurrence.
DISCUSSION: PPMC  is  usually  asymptomatic;  hemoptysis  is  seen  occasionally.  Preoperative  diagnosis  isung cancer
utcomes
very  difﬁcult  to  establish.  Both  FNA  cytology  and  transbronchial  lung  biopsy  seem  inadequate.  Our  patient
went  on  to  undergo  open  lung  biopsy  and  histopathological  testing  that  conﬁrmed  the  diagnosis  of  PMC.
CONCLUSION:  It is  important  to differentiate  this  rare  pathological  feature  of  the  lung from  other  lung
tumors  as the  treatment  is  surgical  rather  than  medical.  Thoracic  surgeons  should  bear  in mind  this
rare  tumor  for  the  differential  diagnosis  of  a pleural  mesothelioma  because  this  tumor  has  a  favorable
prognosis.
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. Introduction
Primary Pulmonary Mucinous Cystadenocarcinoma PPMC is an
xtremely rare variety of lung cancer. PPMC belongs to a group of
ystic neoplasms characterized by extracellular mucin secretion.
hese mucinous neoplasms are histologically similar to well-
ecognized mucinous tumors of the pancreas, breast, and ovary.
reoperative diagnosis is very difﬁcult. This tumor has a remarkably
avorable prognosis.
.  Presentation of case
A 49-year-old former smoker exposed to asbestos was  admit-
ed to our unit of general and thoracic surgery for exploration
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mass in the right lung. The patient had no relevant history of lung
disease, but few months before hospital admission had reported
a pain in the right hemithorax. He had no fever, cough, spu-
tum or hemoptysis. Chest X-ray revealing a solitary tumor in
the right lower lobe of the lung. CT scan of the chest showed
a heterogeneous mass, 5 cm × 7 cm at its maximum diameter in
the inferior lobe of the right lung. The contrast-enhancing tumor
seemed to be pleural (Figs. 1 and 2). We  had suspected pleural
mesothelioma, sarcoma. The case was discussed by multidisci-
plinary oncological team with decision to do wedge resection
without transthoracic CT-guided needle aspiration, bronchoscopy,
or FNA.
Because a malignant tumor could not be ruled out, a thoraco-
tomy and wedge resection of the right lower lobe with sufﬁcient
surgical margin was performed to obtain a deﬁnitive diagnosis.
The postoperative histopathological ﬁndings were in accordance
with the diagnosis of PPMC on cystic adenoid malformation of lung
type 2 (Figs. 3 and 4). Immunohistochemical analysis showed pos-
itive immunostaining for CK 20 (in the mucous glands), TTF1 (in
the serous glands) CK 7 and smooth muscle actin and negative
Open access under CC BY-NC-ND license.immunostaining for CK34, PSA, TTF1 (in the mucous glands), and
CK20 (in the serous glands).
Lobectomy  was  performed. The postoperative period was
simple. The multidisciplinary oncological team decided to do
surveillance. 5 years later, the patient has no recurrence.
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Fig. 1. CT scan of the chest without contrast showed a heterogeneous mass in the
inferior lobe of the right lung (arrow).
Fig. 2. CT scan of the chest with contrast. The contrast-enhancing tumor seemed to
be  pleural.
Fig. 3. The anatomopathologic results. Pulmonary Mucinous Cystadenocarcinoma.Fig. 4. The anatomopathologic results. Pulmonary Mucinous Cystadenocarcinoma.
3. Discussion
Primary Pulmonary Mucinous Cystadenocarcinoma PPMC is an
extremely rare subtype of pulmonary adenocarcinoma,1 with only
a few dozen cases reported in the literature to date.2 Approxi-
mately 2/3 of cases have been associated with tobacco smoking.2
Cases have been reported in patients as young as 29.3 PPMC is
usually asymptomatic.4 Hemoptysis is seen occasionally.4 Preop-
erative diagnosis is very difﬁcult to establish. Both FNA cytology
and transbronchial lung biopsy seem inadequate.
We  report a ﬁrst case of PPMC presenting as a pleural mesothe-
lioma. Indeed, the pain, the asbestos exposure and the CT scan
of the chest evoked pleural mesothelioma. The postoperative
histopathological ﬁndings were in accordance with the diagnosis
of PPMC. Therefore we must have to add the pleural mesothelioma
in the list of differentials diagnostics of PPMC. The histopathologi-
cal differential diagnosis of primary PPMC includes primary lesions
of the lung and metastatic tumors from other organs, especially
the ovary, breast, and pancreas. The biological behavior of PPMC is
generally unknown.
The tumors tend to be well circumscribed by a partial ﬁbrous tis-
sue capsule with central cystic change and copious mucin pooling.2
The thin, ﬁbrous wall circumscribing the tumor is highly character-
istic of this lesion.5
The most effective treatment for PPMC is surgical resection.
Lobectomy is considered to be the standard surgical modality for
PPMC.6 It has much more favorable prognosis than most other
forms of adenocarcinoma7 and most pleural mesothelioma. Cases
have been documented of continued growth of these lesions over
a period of 10 years without symptoms.3 Thorough clinical exami-
nation is necessary to rule out another site of origin. No metastasis
to extrathoracic sites has been reported.
We should have suggested preoperative histological veri-
ﬁcation by means of bronchoscopy and FNA, or transthoracic
CT-guided needle aspiration. May  be we  should have invested
more efforts in establishing preoperative veriﬁcation. Preoperative
histological diagnosis will contribute to prevent an unneccessary
second surgery in general anesthesia, which was required in our
patient. Considering the number of differential diagnoses, it may
be difﬁcult for the pathologist to decide on one deﬁnitive diagnosis
in a frozen section test.
Before the ﬁnal choice of treatment is made, thoracic surgeons
should bear in mind this rare tumor for the differential diagnosis
of a pleural mesothelioma, metastatic lesion and pulmonary cystic
lesion. it is important to differentiate this rare pathological feature
of the lung from other lung tumors as the treatment is surgical
rather than medical. Indeed, this tumor has a remarkably favorable
prognosis.
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